Role of endogenous macrophage inflammatory protein-2 in regulating fever induced by bacterial endotoxin in normal and immunosuppressed rats

Clinical and Experimental Pharmacology and Physiology

Volumn 31, Issue 10, 2004, Pages 723-731

  Miñano, Francisco J ^a,b   Tavares, Eva ^a   Maldonado, Rosario ^a  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Cyclophosphamide; Fever; Leukopenia; Lipopolysaccharide

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; ENDOTOXIN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 2;

ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; BODY TEMPERATURE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL MODEL; FEVER; GRAM NEGATIVE INFECTION; INFLAMMATION; LEUKOCYTE COUNT; LEUKOCYTE DIFFERENTIAL COUNT; LEUKOPENIA; NONHUMAN; RAT;

ANIMALS; BODY TEMPERATURE; FEVER; IMMUNIZATION; IMMUNOSUPPRESSION; KINETICS; LEUKOCYTE COUNT; LEUKOPENIA; LIPOPOLYSACCHARIDES; MALE; MONOKINES; RATS; RATS, WISTAR;

EID: 9144238141     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2004.04086.x     Document Type: Article

References (50)

1. Corey L, Boeckh M. Persistent fever in patients with neutropenia. N. Engl. J. Med. 2002; 346: 222-4.
2. Engel A, Mack E, Kern P, Kern WV. An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever. Gram-negative bacteremia and complicated infection in neutropenic cancer patients. Infection 1998; 26: 213-21.
3. Kern WV, Heiss M, Steinbach G. Prediction of Gram-negative bacteremia in patients with cancer and febrile neutropenia by means of interleukin-8 levels in serum: Targeting empirical monotherapy versus combination therapy. Clin. Infect. Dis. 2001; 32: 832-5.
4. Zeisberger E. From humoral fever to neuroimmunological control of fever. J. Therm. Biol. 1999; 24: 287-326.
5. Scapini P, Lapinet-Vera JA, Gasperini S, Calzetti F, Bazzoni F, Cassatella MA. The neutrophil as a cellular source of chemokines. Immunol. Rev. 2000; 177: 195-203.
6. Conti B, Tabarean I, Andrei C, Bartfai T. Cytokines and fever. Front. Biosci. 2004; 9: 1433-49.
7. Engervall P, Andersson B, Bjorkholm M. Clinical significance of serum cytokine patterns during start of fever in patients with neutropenia. Br. J. Haematol. 1995; 91: 838-45.
8. De Bont ES, Oude Nijhuis C, Kamps WA, Vellenga E. Interpretation of inflammatory markers in feverish cancer patients with or without neutropenia at admission. Br. J. Haematol. 2001; 114: 489-91.
9. Tavares E, Miñano FJ, Maldonado R et al. Serum levels of IL-6 and IL-10 induced by Gram-negative and Gram-positive pyrogens as early-warning predictors of fever in neutropenic rats. J. Interferon Cytokine Res. 2002; 22 (Suppl.): 164 (Abstract).
10. Luster AD. Chemokines: Chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 1993; 338: 436-45.
11. Bajetto A, Bonavia R, Barber S, Florio T, Schettini G. Chemokines and their receptors in the central nervous system. Front. Neuroendocrinol. 2001; 22: 147-84.
12. Keane MP, Strieter RM. Chemokine signalling in inflammation. Crit. Care Med. 2000; 28 (Suppl. 4): N13-26.
13. Wolpe SD, Sherry B, Juers D, Davatelis G, Yurt RW, Cerami A. Identification and characterization of macrophage inflammatory protein 2. Proc. Natl Acad. Sci. USA 1989; 86: 612-16.
14. Tekamp-Olson P, Gallegos C, Bauer D et al. Cloning and characterization of cDNAs for murine macrophage inflammatory protein 2 and its human homologues. J. Exp. Med. 1990; 172: 911-19.
15. Walley KR, Lukacs NW, Standiford TJ, Strieter RM, Kunkel SL. Elevated levels of macrophage inflammatory protein 2 in severe murine peritonitis increase neutrophil recruitment and mortality. Infect. Immun. 1997; 65: 3847-51.
16. Biedermann T, Kneilling M, Mailhammer R et al. Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J. Exp. Med. 2000; 192: 1441-52.
17. Endlich B, Armstrong D, Brodsky J, Novotny M, Hamilton TA. Distinct temporal patterns of macrophage-inflammatory protein-2 and KC chemokine gene expression in surgical injury. J. Immunol. 2002; 168: 3586-94.
18. Schmal H, Shanley TP, Jones ML, Friedl HP, Ward PA. Role for macrophage inflammatory protein-2 in lipopolysaccharide-induced lung injury in rats. J. Immunol. 1996; 156: 1963-72.
19. Kishimoto C, Kawamata H, Sakai S, Shinohara H, Ochiai H. Enhanced production of macrophage inflammatory protein 2 (MIP-2) by in vitro and in vivo infections with encephalomyocarditis virus and modulation of myocarditis with an antibody against MIP-2. J. Virol. 2001; 75: 1294-300.
20. Kopydlowski KM, Salkowski CA, Cody MJ et al. Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo. J. Immunol. 1999; 163: 1537-44.
21. Seebach J, Bartholdi D, Frei K et al. Experimental Listeria meningo-encephalitis. Macrophage inflammatory protein-1 alpha and -2 are produced intrathecally and mediate chemotactic activity in cerebrospinal fluid of infected mice. J. Immunol. 1995; 155: 4367-75.
22. Biedermann T, Kneilling M, Mailhammer R et al. Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J. Exp. Med. 2000; 192: 1441-52.
23. Zampronio AR, Souza GE, Silva CA, Cunha FQ, Ferreira SH. Interleukin-8 induces fever by a prostaglandin-independent mechanism. Am. J. Physiol. 1994; 266: R1670-4.
24. Matzer SP, Baumann T, Lukacs NW, Rollinghoff M, Beuscher HU. Constitutive expression of macrophage-inflammatory protein 2 (MIP-2) mRNA in bone marrow gives rise to peripheral neutrophils with preformed MIP-2 protein. J. Immunol. 2001; 167: 4635-43.
25. Opal SM, Jhung JW, Keith JC et al. Recombinant human interleukin-11 in experimental Pseudomonas aeruginosa sepsis in immunocompromised animals. J. Infect. Dis. 1998; 178: 1205-8.
26. Soszynski D, Kozak W, Rudolph K, Leon LR, Conn CA, Kluger MJ. Hemorrhage suppresses fever, interleukin-6, and tumor necrosis factor-alpha responses to lipopolysaccharide in rats. Neuroimmunomodulation 1996; 3: 239-46.
27. Miñano FJ, Fernandez-Alonso A, Benamar K, Myers RD, Sancibrián M, Armengol JA. Macrophage inflammatory protein-1β (MIP-1β) produced endogenously in rat brain during E. coli fever in rats. Eur. J. Neurosci. 1996; 8: 424-8.
28. Sakai S, Kawamata H, Mantani N et al. Therapeutic effect of antimacrophage inflammatory protein 2 antibody on influenza virus-induced pneumonia in mice. J. Virol. 2000; 74: 2472-6.
29. Standiford TJ, Strieter RM, Lukacs NW, Kunkel SL. Neutralization of IL-10 increases lethality in endotoxemia. Cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor. J. Immunol. 1995; 155: 2222-9.
30. Lentsch AB, Yoshidome H, Cheadle WC, Miller FN, Edwards MJ. Chemokine involvement in hepatic ischemia/reperfusion injury in mice. Roles for macrophage inflammatory protein-2 and Kupffer cells. Hepatology 1998; 27: 507-12.
31. Romanovsky AA, Simons CT, Kulchitsky VA. 'Biphasic' fevers often consist of more than two phases. Am. J. Med. 1998; 275: 323-31.
32. Soker M, Colpan L, Ece A, Devecioglu C, Haspolat K. Serum levels of IL-1 beta, sIL-2R, IL-6, IL-8, and TNF-alpha in febrile children with cancer and neutropenia. Med. Oncol. 2001; 18: 51-7.
33. Zampronio AR, Silva CA, Cunha FQ, Ferreira SH, Pela IR, Souza GE. Indomethacin blocks the febrile response induced by interleukin-8 in rabbits. Am. J. Physiol. 1995; 269: R1469-74.
34. Yoshimura T, Takeya M, Ogata H, Yamashiro S, Modi WS, Gillitzer R. Molecular cloning of the guinea pig GRO gene and its rapid expression in the tissues of lipopolysaccharide-injected guinea pigs. Int. Arch. Allergy Immunol. 1999; 119: 101-11.
35. Kishimoto C, Kawamata H. Sakai S, Shinohara H, Ochiai H. Enhanced production of macrophage inflammatory protein 2 (MIP-2) by in vitro and in vivo infections with encephalomyocarditis virus and modulation of myocarditis with an antibody against MIP-2. J. Virol. 2001; 75: 1294-300.
36. Li Z, Blatteis CM. Fever onset is linked to the appearance of lipopolysaccharide in the liver. Endotoxin Res. 2004; 10: 39-53.
37. Cartmell T, Ball C, Bristow AF, Mitchell D, Poole S. Endogenous interleukin-10 is required for the defervescence of fever evoked by local lipopolysaccharide-induced and Staphylococcus aureus-induced inflammation in rats. J. Physiol. 2003; 549: 653-64.
38. Brengman ML, Wang D, Wilkins KB et al. Hepatic killing but not clearance of systemically circulating bacteria is dependent upon peripheral leukocytes via Mac-1 (CD11b/CD18). Shock 2003; 19: 263-7.
39. Malhi H, Annamaneni P, Slehria S et al. Cyclophosphamide disrupts hepatic sinusoidal endothelin and improves transplanted cell engraftment in rat liver. Hepatology 2002; 36: 112-21.
40. Anton E. Ultrastructural changes of stromal cells of bone marrow and liver after cyclophosphamide treatment in mice. Tissue Cell 1997; 29: 1-9.
41. Matsumoto T, Tateda K, Miyazaki S et al. Effect of antiflagellar human monoclonal antibody on gut-derived Pseudomonas aeruginosa sepsis in mice. Clin. Diagn. Lab. Immunol. 1999; 6: 537-41.
42. Malhi H, Annamaneni P, Slehria S et al. Cyclophosphamide disrupts hepatic sinusoidal endothelium and improves transplanted cell engraftment in rat liver. Hepatology 2002; 36: 112-21.
43. Artym J, Zimecki M, Paprocka M, Kruzel ML. Orally administered lactoferrin restores humoral immune response in immunocompromised mice. Immunol. Lett. 2003; 89: 9-15.
44. Kluger MA. Fever: Role of pyrogens and cryogens. Physiol. Rev. 1991; 71: 93-127.
45. Cassatella MA. The production of cytokines by polymorphonuclear neutrophils. Immunol. Today 1995; 16: 21-6.
46. Sakic B, Laflamme N, Crnic LS, Szechtman H, Denburg JA, Rivest S. Reduced corticotropin-releasing factor and enhanced vasopressin gene expression in brains of mice with autoimmunity-induced behavioral dysfunction. J. Neuroimmunol. 1999; 96: 80-91.
47. Miñano FJ, Sancibrian M, Vizcaíno M et al. Macrophage inflammatory protein-1: Unique action on hypothalamus to evoke fever. Brain Res. Bull. 1990; 24: 849-52.
48. Smith JA. Neutrophils, host defense, and inflammation: A double-edged sword. J. Leukoc. Biol. 1994; 56: 672-86.
49. Tavares E, Miñano FJ. RANTES: A new prostaglandin dependent endogenous pyrogen in the rat. Neuropharmacology 2000; 39: 2505-13.
50. Tavares E, Miñano FJ. Differential sensitivities of pyrogenic chemokine fevers to cyclooxygenase isozymes antibodies. Brain Res. Bull. 2002; 59: 181-7.